SGLT2 inhibitors provide an effective therapeutic option for diabetes complicated with insulin antibodies.

Abstract

Diabetes mellitus complicated with insulin antibodies is rare in clinical practice but usually difficult to control. A high amount of insulin antibodies, especially with low affinity and high binding capacity, leads to unstable glycemic control characterized by hyperglycemia unresponsive to large volume of insulin and unanticipated hypoglycemia. There are… (More)
DOI: 10.1507/endocrj.EJ15-0523

Topics

Cite this paper

@article{Hayashi2016SGLT2IP, title={SGLT2 inhibitors provide an effective therapeutic option for diabetes complicated with insulin antibodies.}, author={Akinori Hayashi and Koji Takano and Sayuki Kawai and Masayoshi Shichiri}, journal={Endocrine journal}, year={2016}, volume={63 2}, pages={187-91} }